Showing results (111-120 of 447) with videos related to
Sort By:
Pageof 45
Pediatric Diabetes|July 27, 2017
Transglutaminase antibodies and celiac disease in children with type 1 diabetes and in their family membersAnna Parkkola, Taina Härkönen, Samppa J Ryhänen, et al.Diabetes Care|May 5, 2026
COVID-19 Vaccinations, SARS-CoV-2 Infections, and Type 1 Diabetes in Finnish ChildrenSusanna Tall, Jenni Pettersson, Taina Härkönen, et al.Journal of Autoimmunity|April 15, 2005
Absence of avidity maturation of autoantibodies to the protein tyrosine phosphatase-like IA-2 molecule and glutamic acid decarboxylase (GAD65) during progression to type 1 diabetesAnnette Westerlund, Matti Ankelo, Jorma Ilonen, et al.Journal of Evaluation in Clinical Practice|May 9, 2008
Agreement between parental reports and patient records in food allergies among infants and young children in FinlandJetta Tuokkola, Minna Kaila, Pirjo Pietinen, et al.Diabetologia|May 20, 2015
OGTT and random plasma glucose in the prediction of type 1 diabetes and time to diagnosisOlli Helminen, Susanna Aspholm, Tytti Pokka, et al.Pediatric Diabetes|February 16, 2012
Expansion of CD4+CD25+FOXP3+ regulatory T cells in infants of mothers with type 1 diabetesKristiina Luopajärvi, Janne K Nieminen, Jorma Ilonen, et al.Pediatric Diabetes|January 29, 2008
Does the secular increase in body mass in children contribute to the increasing incidence of type 1 diabetes?Mikael Knip, Antti Reunanen, Suvi M Virtanen, et al.Microbiome|February 7, 2025
Modulating the developing gut microbiota with 2'-fucosyllactose and pooled human milk oligosaccharidesSimone Renwick, Annalee Furst, Mikael Knip, et al.Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|January 13, 2021
Effect of extensively hydrolyzed casein vs. conventional formula on the risk of asthma and allergies: The TRIGR randomized clinical trialSuvi M Virtanen, David Cuthbertson, Marisa Couluris, et al.Pharmacoeconomics|March 12, 2003
A simulation model for estimating direct costs of type 1 diabetes preventionJarmo Hahl, Tuula Simell, Antti Kupila, et al.Pageof 45